(Q46764365)

25 December 2017

title

Pharmacological potential of phytoestrogens in the treatment of prostate cancer (English)

1 reference

25 December 2017

author name string

P Thelen

1

1 reference

25 December 2017

F Seseke

2

1 reference

25 December 2017

R-H Ringert

3

1 reference

25 December 2017

W Wuttke

4

1 reference

25 December 2017

D Seidlová-Wuttke

5

1 reference

25 December 2017

language of work or name

German

0 references

publication date

1 February 2006

1 reference

25 December 2017

published in

Der Urologe. Ausg. A

1 reference

25 December 2017

volume

45

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

195-6, 197-201

1 reference

25 December 2017

Phyto-oestrogens and Western diseases

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00120-005-0932-3

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

12 December 2020

Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

1 reference

12 December 2020

Phytoestrogens: recent developments.

1 reference

12 December 2020

Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis

1 reference

12 December 2020

Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail

1 reference

12 December 2020

Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

1 reference

12 December 2020

Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells

1 reference

12 December 2020

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression

1 reference

12 December 2020

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

1 reference

12 December 2020

Unconventional therapy for prostate cancer: good, bad or questionable?

1 reference

12 December 2020

Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer

1 reference

12 December 2020

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease

1 reference

12 December 2020

Phytoestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro.

1 reference

12 December 2020

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

1 reference

12 December 2020

Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model

1 reference

12 December 2020

Diet and its preventive role in prostatic disease

1 reference

12 December 2020

10.1007/S00120-005-0932-3

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017